Citation Impact
Citing Papers
Epigenetic Repression of DNA Mismatch Repair by Inflammation and Hypoxia in Inflammatory Bowel Disease–Associated Colorectal Cancer
2009 StandoutNobel
Transient Ablation of Regulatory T cells Improves Antitumor Immunity in Colitis-Associated Colon Cancer
2014 StandoutNobel
Tumour-cell invasion and migration: diversity and escape mechanisms
2003 Standout
Morphology of sporadic colorectal cancer with DNA replication errors
1998
Neoadjuvant anastrozole versus tamoxifen in patients receiving goserelin for premenopausal breast cancer (STAGE): a double-blind, randomised phase 3 trial
2012
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials
2011 Standout
Mismatch repair, genetic stability and tumour avoidance
1995 StandoutNobel
Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer
2006 Standout
Dendritic cells in cancer immunology and immunotherapy
2019 Standout
30 years' follow up of randomised studies of adjuvant CMF in operable breast cancer: cohort study
2005
Liver metastases from colorectal adenocarcinomas grow in three patterns with different angiogenesis and desmoplasia
2001
Breast cancer
2016 Standout
Stressful Events, Pessimism, Natural Killer Cell Cytotoxicity, and Cytotoxic/Suppressor T Cells in HIV+ Black Women at Risk for Cervical Cancer
1998
Epithelial-Mesenchymal Transitions in Development and Disease
2009 Standout
Human ADAR1 Prevents Endogenous RNA from Triggering Translational Shutdown
2018 StandoutNobel
Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer
2005 Standout
Epidermal growth factor receptor immunohistochemical reactivity in patients with American Joint Committee on Cancer Stage IV colon adenocarcinoma
2001
A genetic model for colorectal tumorigenesis
1990 Standout
High Myeloperoxidase Positive Cell Infiltration in Colorectal Cancer Is an Independent Favorable Prognostic Factor
2013
Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients
1992
Quality of Life in Long-Term, Disease-Free Survivors of Breast Cancer: a Follow-up Study
2002 Standout
Second international consensus guidelines for breast cancer in young women (BCY2)
2016
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
2004 Standout
From dukes through jass: Pathological prognostic indicators in rectal cancer
1994
Microsatellite Instability and 8p Allelic Imbalance in Stage B2 and C Colorectal Cancers
1999
Colorectal cancer
2013 Standout
S-100 protein-positive dendritic cells in colorectal adenocarcinomas. Distribution and relation to the clinical prognosis
1989
Antitumour actions of interferons: implications for cancer therapy
2016
A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 ( SMAD4)
2004 Standout
Ultrastructural study of TPA-induced cell motility: human well-differentiated rectal adenocarcinoma cells move as coherent sheets via localized modulation of cell-cell adhesion
1995
Phenotype of Microsatellite Unstable Colorectal Carcinomas: Well-Differentiated and Focally Mucinous Tumors and the Absence of Dirty Necrosis Correlate With Microsatellite Instability
2003
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Classification of colorectal cancer based on correlation of clinical, morphological and molecular features
2006
Trastuzumab — Mechanism of Action and Use in Clinical Practice
2007 Standout
CD8+ lymphocytes/ tumour-budding index: an independent prognostic factor representing a ‘pro-/anti-tumour’ approach to tumour host interaction in colorectal cancer
2009
Identification of occult micrometastases in pericolic lymph nodes of Dukes' B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Correlation with long-term survival
1994
Histopathological predictors of regional lymph node metastasis at the invasive front in early colorectal cancer
2011
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Regulatory T cells in cancer immunotherapy
2016 StandoutNobel
HPV Vaccine against Anal HPV Infection and Anal Intraepithelial Neoplasia
2011 Standout
Hereditary Colorectal Cancer
2003 Standout
Tumour-educated macrophages promote tumour progression and metastasis
2004 Standout
Care of the Cancer Survivor: Metabolic Syndrome after Hormone-Modifying Therapy
2009
Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic Cancer
2007 Standout
The immune contexture in human tumours: impact on clinical outcome
2012 Standout
Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon Carcinoma
1990 Standout
Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: An updated review
1993
Paradoxical roles of the immune system during cancer development
2006 Standout
MULTIPLE GENETIC ALTERATIONS IN DISTAL AND PROXIMAL COLORECTAL CANCER
1989
Potentially curative surgery of colon cancer: patterns of failure and survival.
1988
A randomized placebo-controlled study of tamoxifen after adjuvant chemotherapy in premenopausal women with early breast cancer (National Cancer Institute of Canada—Clinical Trials Group Trial, MA.12)
2009
Estimation and external validation of a new prognostic model for predicting recurrence-free survival for early breast cancer patients in the UK
2010
Tumour budding in colorectal carcinoma
2006
Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell derived exosomes
1998 Standout
Tumor metastasis: mechanistic insights and clinical challenges
2006 Standout
Mutation in the DNA mismatch repair gene homologue hMLH 1 is associated with hereditary non-polyposis colon cancer
1994 StandoutNature
Mismatch Repair Deficiency in Phenotypically Normal Human Cells
1995 StandoutScienceNobel
Colorectal cancer prognosis depends on T-cell infiltration and molecular characteristics of the tumor
2011
Neutrophils in cancer: neutral no more
2016 Standout
Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial
2010
Quality criteria were proposed for measurement properties of health status questionnaires
2006 Standout
Psychological Stress and the Human Immune System: A Meta-Analytic Study of 30 Years of Inquiry.
2004 Standout
American Joint Committee on Cancer prognostic factors consensus conference
2000
Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy
2008
Prognostic role of CD8+ tumor-infiltrating lymphocytes in stage III colorectal cancer with and without microsatellite instability
2004
Non-specific low back pain
2011 Standout
Extended adjuvant endocrine therapy in hormone-receptor positive early breast cancer: Current and future evidence
2015
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
First international consensus guidelines for breast cancer in young women (BCY1)
2014
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2015
Longer Therapy, Iatrogenic Amenorrhea, and Survival in Early Breast Cancer
2010
Oestrogen exposure and breast cancer risk
2003
Systematic review of LHRH agonists for the adjuvant treatment of early breast cancer
2005
Aetiological parallel between anal cancer and cervical cancer
1991
Colorectal Carcinoma: Diagnostic, Prognostic, and Molecular Features
2003
Reliable and Valid Self-Report Outcome Measures in Sexual (Dys)function: A Systematic Review
2002
Evolution of hereditary non-polyposis colorectal cancer.
1992
Riding the Crest of the Teachable Moment: Promoting Long-Term Health After the Diagnosis of Cancer
2005 Standout
Lymphatic Mapping and Sentinel Node Biopsy in the Patient With Breast Cancer
1996 Standout
Tamoxifen for the Prevention of Breast Cancer: Psychosocial Impact on Women Participating in Two Randomized Controlled Trials
2001
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
The Three Es of Cancer Immunoediting
2004 Standout
Zoledronic Acid Prevents Cancer Treatment–Induced Bone Loss in Premenopausal Women Receiving Adjuvant Endocrine Therapy for Hormone-Responsive Breast Cancer: A Report From the Austrian Breast and Colorectal Cancer Study Group
2006
American Society of Clinical Oncology Recommendations on Fertility Preservation in Cancer Patients
2006 Standout
Breast Cancer Treatment
2019 Standout
Juvenile polyposis–a precancerous condition
1988
Tumor Microsatellite-Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon Cancer
2003 Standout
Evaluation of Treatment-Effect Heterogeneity Using Biomarkers Measured on a Continuous Scale: Subpopulation Treatment Effect Pattern Plot
2010
Letrozole Therapy Alone or in Sequence with Tamoxifen in Women with Breast Cancer
2009
Randomized Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy and Palliative Surgery in Patients With Peritoneal Carcinomatosis of Colorectal Cancer
2003 Standout
Prognostic value of intratumoral natural killer cells in gastric carcinoma
2000
Quality of Life in Goserelin-Treated Versus Cyclophosphamide + Methotrexate + Fluorouracil–Treated Premenopausal and Perimenopausal Patients With Node-Positive, Early Breast Cancer: The Zoladex Early Breast Cancer Research Association Trialists Group
2003
NCCN Task Force Report: Adjuvant Therapy for Breast Cancer
2006
Hypoxic retinal Müller cells promote vascular permeability by HIF-1–dependent up-regulation of angiopoietin-like 4
2013 StandoutNobel
Restoration of mismatch repair to nuclear extracts of H6 colorectal tumor cells by a heterodimer of human MutL homologs.
1995 StandoutNobel
Meeting Highlights: Updated International Expert Consensus on the Primary Therapy of Early Breast Cancer
2003
Effector Memory T Cells, Early Metastasis, and Survival in Colorectal Cancer
2005 Standout
Chemoendocrine Therapy for Premenopausal Women With Axillary Lymph Node–Positive, Steroid Hormone Receptor–Positive Breast Cancer: Results From INT 0101 (E5188)
2005
High frequency of tumor‐infiltrating FOXP3+ regulatory T cells predicts improved survival in mismatch repair‐proficient colorectal cancer patients
2009
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
2018 Standout
American Joint Committee on Cancer Prognostic Factors Consensus Conference
1999
Suppression of Human Colorectal Carcinoma Cell Growth by Wild-Type p53
1990 StandoutScience
Tamoxifen After Adjuvant Chemotherapy for Premenopausal Women With Lymph Node-Positive Breast Cancer: International Breast Cancer Study Group Trial 13-93
2006
Works of J. Cuzick being referenced
Anal cancer and marital status
1990
The Sexual Activity Questionnaire: A measure of women's sexual functioning
1996
Should aromatase inhibitors be used as initial adjuvant treatment or sequenced after tamoxifen?
2006
Use of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive breast cancer: a meta-analysis of individual patient data from randomised adjuvant trials
2007
Survival analyses from the ZEBRA study
2003
The grading of rectal cancer: historical perspectives and a multivariate analysis of 447 cases
1986
Value of flow cytometric determination of ploidy as a guide to prognosis in operable rectal cancer: a multivariate analysis
1987
Goserelin Versus Cyclophosphamide, Methotrexate, and Fluorouracil as Adjuvant Therapy in Premenopausal Patients With Node-Positive Breast Cancer: The Zoladex Early Breast Cancer Research Association Study
2002
Possible cofactors in the etiology of cervical intraepithelial neoplasia. An immunopathologic study.
1989
A trial of human alpha interferon as an adjuvant agent in breast cancer after loco-regional recurrence.
1987